MSCI Considers Major Index Rule Change for Crypto-Heavy Companies
15.12.2025 - 09:48:05Msci US55354G1004
The global index provider MSCI is at the center of a significant market debate. The firm is evaluating a potential revision to its index construction rules that would exclude companies holding substantial cryptocurrency assets, a move with profound implications for major technology indices and the passive funds that track them. A final decision on the proposed rule is anticipated in January 2026.
At the heart of the review is a plan to bar so-called "Digital Asset Treasuries" (DATs) from certain indices if their digital currency holdings exceed 50% of total assets. This criterion would directly affect firms like Strategy, formerly known as MicroStrategy. While Strategy recently retained its position in the Nasdaq-100 during the December 13 rebalancing, a formal ruling from MSCI could dramatically alter index compositions.
Market analysts have quantified a potential consequence: forced selling by passive investment vehicles could reach an estimated $2.8 billion if affected stocks are removed. Such a substantial reallocation would likely exert immediate downward pressure on the share prices of these companies and on related ETFs, as fund managers adjust portfolios to mirror the revised indices.
Institutional Moves and Product Expansion
Amid this debate, institutional interest in MSCI's own stock shows mixed signals. Investment firm Caxton Associates reported a substantial 279.4% increase in its stake during the second quarter, acquiring 12,823 shares valued at approximately $7.4 million. Conversely, MSCI's CFO, Andrew Wiechmann, sold 450 shares worth $247,500 on December 11. He retains over 21,000 shares, suggesting the transaction was a routine partial divestment.
Should investors sell immediately? Or is it worth buying Msci?
Separately, MSCI continues to broaden its product suite. The newly launched MSCI All Country Public + Private Equity Index merges the traditional ACWI IMI with a private equity component, targeting a 15% allocation to private markets. This development responds to growing investor demand for hybrid benchmarks that encompass both public and private assets.
Financial Performance and Market Outlook
- Share Price & Technicals: MSCI shares are currently trading at €471.90, approximately 21.6% below their 52-week high of €602.20. The price sits below both its 50-day (€481.91) and 200-day (€487.24) moving averages.
- Fundamental Metrics: Latest quarterly results showed earnings per share of $4.47, surpassing the $4.37 estimate. Revenue reached $793.43 million, a 9.5% year-over-year increase. The company trades at a price-to-earnings ratio of 33.9x, above the industry average of 25.2x, and carries a market capitalization of about $41.4 billion.
- Capital Allocation & Sentiment: The board has authorized a new share repurchase program of up to $3.0 billion, which could retire as much as 7.1% of outstanding shares. Analyst consensus currently rates the stock a "Moderate Buy," with 8 out of 12 tracked firms issuing a buy recommendation.
The path forward hinges on MSCI's ultimate decision. Implementing the exclusion rule would trigger the aforementioned wave of passive selling. Choosing not to proceed, however, would likely ease regulatory uncertainty for crypto-centric firms and help stabilize interest from more conservative investors. From a technical perspective, MSCI's stock would need to close decisively above its 200-day moving average (€487.24) to break its current negative consolidation; sustained weakness below these key averages may invite further selling pressure.
The market impact will remain uncertain until MSCI publishes its final ruling in January 2026. Until then, outcomes depend on the precise formulation of the eligibility criteria and the subsequent reaction from the massive passive investment ecosystem.
Ad
Msci Stock: Buy or Sell?! New Msci Analysis from December 15 delivers the answer:
The latest Msci figures speak for themselves: Urgent action needed for Msci investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 15.
Msci: Buy or sell? Read more here...


